Century Therapeutics
Price & Volume
Stats
See moreOpen | $2.19 |
Previous Close | $2.24 |
Day Range | $2.17-$2.34 |
52W Range | $0.34-$2.71 |
Market Cap | $190.5M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $113.3M |
Revenue Growth (YoY) | 12,667.7% |
Gross Profit (12 Mos) | $7.9M |
Diluted EPS | -$0.32 |
News
See moreYahoo Finance • 11 days ago
IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Yahoo Finance • 25 days ago
Cheap high flyer healthcare stocks - high momentum and low valuation
Yahoo Finance • 3 months ago
Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors
Yahoo Finance • 4 months ago
Century Therapeutics GAAP EPS of -$0.40 misses by $0.06, revenue of $0M
About
CEO | Dr. Brent Pfeiffenberger M.B.A., Pharm.D. |
Address | 25 North 38th Street, Philadelphia, PA, United States, 19104 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 140 |
